Ulcerative colitis (UC) flares can be exhausting, sometimes sending you to the bathroom 10 or more times a day. If standard treatments aren’t providing relief, a clinical trial may offer a new option. Eligible participants can receive compensation for their time and travel while contributing to the advancement of UC care
You May Qualify If You:
⦁ Are 18 to 75 years old
⦁ Have a confirmed diagnosis of ulcerative colitis (verified by medical records)
⦁ Are currently experiencing symptoms, such as increased stool frequency and rectal bleeding
⦁ Are willing to undergo an endoscopy with biopsies
⦁ Have had a lack of response, loss of response, or intolerance to conventional treatments, including but not limited to:
⦁ Mesalamine (Lialda, Apriso), Sulfasalazine
⦁ Prednisone, Budesonide
⦁ Biologic treatments (e.g., Stelara, Remicade, Humira)
⦁ Meet additional eligibility criteria as determined by the study team
You May Not Qualify If You:
⦁ Have had extensive colon surgery
⦁ Have a history of cancer
⦁ Have chronic kidney disease
⦁ Struggle with drug or alcohol abuse
⦁ Plan to become pregnant during the study